
January 2008
Printer-friendly version
Compliance of Joint Commission stroke
measures shows significant reduction of complications and reduced
recurrence risk
By Thomas Habiger, M.D.
Planning for St. John’s
Stroke Center began in May 1998 with a multi-disciplinary team. The vision
for the Stroke Center was to integrate comprehensive care through a
multidisciplinary team servicing a single site. The focus of the Stroke
Center was to provide the highest quality care possible for the stroke
patient, to provide this care at the lowest cost, and to provide stroke
education to the public.
The Stroke Team Active
Responders (STAR) are called to rapidly respond and treat acute stroke,
including providing thrombolytic therapy with t-PA. Available 24 hours a
day, seven days a week. This team consists of four St. John’s neurologists
and four Stroke Center Coordinators and a neurointerventionalist for
intrarterial t-PA. The STAR team responds to both ETC and in-house
interventions.
St. John’s Stroke Center
was one of 17 multi-hospital specialty centers in the United States
participating in the American Academy of Neurology’s (AAN) and the
American Stroke Association’s, Stroke Practice Improvement Network
(SPIN).
The overall objective was
to develop and implement a model of a national stroke performance
improvement network sponsored by a professional society. St. John’s
Stroke Center was one of 6 hospitals randomized to perform stroke
benchmarking for SPIN in the areas of bedside dysphagia screening, DVT
prophylaxis, A-fib and Coumadin compliance, t-PA within one hour of ETC
arrival.
St. John’s Stroke Center
was one of 33 hospitals in the United States participating as a pilot-test
site for The Joint Commission Disease-Specific Care (DSC) Stroke Pilot
Measure Project from Oct. 1, 2004 through Sept. 30, 2005.
The project goal was to
evaluate a standardized set of performance measures for stroke inpatient
care that have great potential for improving the quality of stroke care.
Measures collected were DVT prophylaxis, discharged on antithrombotics,
patients with Atrial Fibrillation receiving anticoagulation therapy,
Tissue Plasminogen Activator (t-PA) considered, antithrombotic medication
within 48 hours of hospitalization, lipid profile, screen for dysphagia,
stroke education, smoking cessation, and a plan for rehabilitation was
considered.
The performance measures
collected for SPIN and JCAHO’s Disease-Specific Care Stroke Pilot Measure
Project have been incorporated into the American Stroke Association stroke
database registry, Get With The Guidelines (GWTG)-Stroke.
Consistent compliance of using
standard treatment protocols for these core measures has shown significant
reductions of the complications of stroke and a reduced risk of a recurrent
stroke, which is greatest in the subsequent three months. Using
stroke order
sets from St. John’s Internet incorporates the appropriate treatments for the
core measures and improves compliance, resulting in improved outcomes.
The accompanying
sheet outlining the acute stroke core
measures is placed on the inpatient chart to help remind the treating team
of appropriate goals. I would also ask any St. John’s admitting
doctor to briefly review this sheet to familiarize yourself with the core
measures.
In February of 2004, St.
John’s Stroke Center became one of the first eight stroke centers in the
nation to achieve Primary Stroke Center Certification from the Joint
Commission Disease-Specific Care Program by JCAHO. This certification is
indicative of our program’s compliance with consensus-based national
standards; effective use of established clinical practice guidelines to
manage and optimize care; and performance measurement and improvement
activities.
St. John’s Stroke Center
has met many of the goals that were originally set in 1998. As changes
occur in the medical field, our focus is then redefined and refined to
meet the changes.
We continue to provide the
highest quality care possible for the stroke patient by participating in
clinical research trials including IMS III, which is a NIH sponsored trial
of IV t-PA compared to combination IV and IA t-PA. We continue to provide
this care in an attempt to prevent an individual from having a physically,
financially and emotionally devastating stroke.
I recently received a
letter from a patient we treated with t-PA several years ago which I would
like to share with you:
Dear Dr.
Habiger,
You may
not remember me, but I met you in St. John’s ER on March 23, 2000. I was a
freshman at SMS, now Missouri State University, and I had a stroke. On
that day you saved my life and I am now getting married! I am sending you
this invitation as a THANK YOU from my family and myself for all that you
did for me. I am currently a kindergarten teacher in the St. Louis area
and I am doing wonderful! Because of everything you did for me, all of my
dreams are coming true. Thank you so much again and I will never forget
what you have done for me.
Sincerely,
B
|